Passionate about using statistics to support oncology research in fighting cancer.
I provide statistical input into the design, conduct and analysis of clinical trials. I am involved in a number of cancer and non-cancer trials at different stage, including early phase and phase II trials. Some of these projects include PACMEL, SIMPLE, ATOM, FuroHF, ROSA, BKM120 and BOSS. I also work as part of Trial Steering Committees, Trial Management Committees, and Data and Safety Monitoring Committees. In addition, I collaborate on systematic reviews with the CSM’s methodology team.
Beyond my medical statistics skills, I have expertise in survey and sample design, estimation, index number and census methodology, gained through two years’ experience at the National Statistics Office (NSO) in Eritrea. I also have lecturing experience, specialising in teaching introductory statistics, biometry and experimental design at the undergraduate level.
I have research interests in the field of survival analysis, specifically in the area of Cox proportional hazard model and methods beyond proportional hazard model. I first came across this scenario during the final analysis of the PACMEL trial and shared my experience at the annual conference in survival analysis for junior researchers 2017 at the University of Leicester.
I obtained my BSc in Statistics and Demography from the University of Asmara, Eritrea in 2004. In 2009, I was awarded a Chinese government scholarship for international students, through which I completed a Master's degree in Quantitative Economics at the Wuhan University of Technology (WUT), China in 2011. In 2015 I completed an MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine (LSHTM), funded by a UK-EU tuition fee scholarship and the Council for Assisting Refugee Academics (CARA). I joined the Centre for Statistics in Medicine in November 2015 as a medical statistician.
In my free time, I volunteer as a support worker with Refugee Resource, helping refugees and homeless people in Oxford.
A practical application of time to event analysis in the presence of non-proportional hazards
Mohammed SB. et al, (2017)
A randomised phase 2 study of Paclitaxel with or without Trametinib or Pazopanib in advanced wild type BRAF melanoma
Middleton MR. et al, (2017)
Psallidas I. et al, (2017), BMJ open respiratory research, 4
A Randomised Controlled Trial Of The Effect Of CPAP On Diabetic Macular Oedema In People With Concurrent Obstructive Sleep Apnoea
West SD. et al
Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
McGowan DR. et al